Variant report

Variant	nsv589286
Chromosome Location	chr3:269338-283747
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

Extended variants
information (count: 800 )
Associated
traits (count: 84 )

Variant overlapped rSNPs/rCNVs (count:800 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs2055315	chr3:269338-269339	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs566620866	chr3:269376-269377	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs533750659	chr3:269425-269426	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs555697445	chr3:269441-269442	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs539755323	chr3:269477-269478	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs115104381	chr3:269502-269503	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs572816730	chr3:269514-269515	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs182768596	chr3:269574-269575	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs7648273	chr3:269578-269579	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs140447099	chr3:269625-269626	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs542436254	chr3:269634-269635	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs563910726	chr3:269652-269653	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs187453031	chr3:269687-269688	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs549955238	chr3:269694-269695	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs190711357	chr3:269698-269699	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs112504770	chr3:269740-269741	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs183275779	chr3:269753-269754	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs546739139	chr3:269754-269755	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs537825164	chr3:269776-269777	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs556220973	chr3:269778-269779	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs535599708	chr3:269820-269821	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs575564234	chr3:269830-269831	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs73815945	chr3:269839-269840	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs568739359	chr3:269841-269842	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs539324423	chr3:269848-269849	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs558047160	chr3:269860-269861	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs150159009	chr3:269868-269869	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs533783961	chr3:269877-269878	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs555447075	chr3:269879-269880	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs17009026	chr3:269910-269911	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs544359805	chr3:269913-269914	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs138653491	chr3:269915-269916	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs17009028	chr3:269929-269930	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
34	rs546146787	chr3:269964-269965	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs542349861	chr3:269968-269969	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs367802184	chr3:269970-269971	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs559998626	chr3:269986-269987	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs116398979	chr3:270008-270009	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs528429331	chr3:270022-270023	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs187939939	chr3:270027-270028	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs17009045	chr3:270031-270032	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs529325929	chr3:270058-270059	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs142795469	chr3:270086-270087	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs568924196	chr3:270107-270108	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs192231813	chr3:270111-270112	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs74832221	chr3:270137-270138	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs184612926	chr3:270142-270143	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs139815023	chr3:270162-270163	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs4003420	chr3:270163-270164	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs533880867	chr3:270185-270186	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:84)

Disease	PMID	Source
Cancer	20164920	CNVD
Lung cancer	16618734	CNVD
Autism	18349135	CNVD
Breast cancer	20409316	CNVD
Myelofibrosis	22110671	CNVD
Autism	22241247	CNVD
Intellectual disability	22045946	CNVD
Squamous cell cancer	19607727	CNVD
Gastric adenocarcinoma	19115996	CNVD
sporadic birth defects	19047251	CNVD
Mental retardation	17124404	CNVD
abnormal development	18461090	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Sudden cardiac death	19188705	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Ovarian cancer	21720365	CNVD
Neuroblastoma	18923191	CNVD
Papillary thyroid carcinoma	21436994	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Breast cancer	17603634	CNVD
Neuroblastoma	17327916	CNVD
Glioblastoma multiforme	21080181	CNVD
Colorectal cancer	21297112	CNVD
Lynch syndrome	18415027	CNVD
Renal cell carcinoma	18592004	CNVD
Acute myeloid leukemia	20729466	CNVD
Urothelial carcinoma	18382360	CNVD
Melanoma	18172304	CNVD
Cervical cancer	21062161	CNVD
Hirschsprung''s Disease	21712996	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Insulin resistance	16721378	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Ewing''s sarcoma	21437220	CNVD
Neuroblastoma	21484798	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Oral cancer	19627613	CNVD
Renal cell carcinoma	19461508	CNVD
Epithelial cancer	22065749	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Acute myeloid leukemia	16864856	CNVD
Liposarcoma	21253554	CNVD
Basal cell lymphoma	21115979	CNVD
Endometrial cancer	22040021	CNVD
Pancreatic endocrine tumor	20981439	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	17387387	CNVD
Oral cancer	21386901	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Retinoblastoma	21504564	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21364760	CNVD
Schizophrenia	20967226	CNVD
Autism	22543975	CNVD
Attention deficit hyperactivity disorder	19546859	CNVD
lymphocytic leukemia	21291569	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Non-syndromic sensorineural hearing loss	17289997	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Renal cell carcinoma	21668985	CNVD
Tetralogy of Fallot	22912587	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Autism	20685689	CNVD
Melanoma	20877625	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Multiple myeloma	17550852	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:88 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:268400-271000	Weak transcription	Ovary	ovary
2	chr3:269200-270200	Weak transcription	Pancreatic Islets	Pancreatic Islet
3	chr3:269400-269600	Enhancers	Brain Anterior Caudate	brain
4	chr3:269400-271200	Enhancers	Breast Myoepithelial Primary Cells	Breast
5	chr3:269600-271000	Weak transcription	Brain Anterior Caudate	brain
6	chr3:270000-271800	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
7	chr3:270200-270600	Enhancers	Pancreatic Islets	Pancreatic Islet
8	chr3:270200-272200	Enhancers	Cortex derived primary cultured neurospheres	brain
9	chr3:270200-272800	Enhancers	Brain Germinal Matrix	brain
10	chr3:270400-271400	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
11	chr3:270400-272000	Enhancers	HMEC	breast
12	chr3:270600-270800	Enhancers	iPS-18 Cell Line	embryonic stem cell
13	chr3:270600-271000	Active TSS	Pancreatic Islets	Pancreatic Islet
14	chr3:270600-271000	Enhancers	NHEK	skin
15	chr3:270600-272000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
16	chr3:270800-271400	Enhancers	iPS-20b Cell Line	embryonic stem cell
17	chr3:270800-271800	Weak transcription	iPS-18 Cell Line	embryonic stem cell
18	chr3:270800-272600	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
19	chr3:271000-271200	Flanking Active TSS	Ovary	ovary
20	chr3:271000-271400	Enhancers	H9 Cell Line	embryonic stem cell
21	chr3:271000-271400	Flanking Active TSS	NHEK	skin
22	chr3:271000-271600	Enhancers	Brain Anterior Caudate	brain
23	chr3:271000-271800	Enhancers	H1 Cell Line	embryonic stem cell
24	chr3:271000-271800	Enhancers	Fetal Lung	lung
25	chr3:271000-272000	Enhancers	ES-I3 Cell Line	embryonic stem cell
26	chr3:271000-272200	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
27	chr3:271000-272200	Enhancers	Brain Hippocampus Middle	brain
28	chr3:271000-274800	Weak transcription	Pancreatic Islets	Pancreatic Islet
29	chr3:271200-271600	Enhancers	HUES64 Cell Line	embryonic stem cell
30	chr3:271200-271600	Flanking Active TSS	Breast Myoepithelial Primary Cells	Breast
31	chr3:271200-271600	Active TSS	Ovary	ovary
32	chr3:271200-272000	Enhancers	iPS-15b Cell Line	embryonic stem cell
33	chr3:271200-272400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
34	chr3:271400-271800	Enhancers	NHEK	skin
35	chr3:271400-272200	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
36	chr3:271400-272600	Enhancers	HUES48 Cell Line	embryonic stem cell
37	chr3:271600-272000	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
38	chr3:271600-272200	Enhancers	Breast Myoepithelial Primary Cells	Breast
39	chr3:271600-272200	Enhancers	Fetal Brain Male	brain
40	chr3:271600-276000	Weak transcription	Brain Anterior Caudate	brain
41	chr3:271600-284800	Weak transcription	Ovary	ovary
42	chr3:271800-272200	Enhancers	iPS-18 Cell Line	embryonic stem cell
43	chr3:271800-272600	Enhancers	Fetal Brain Female	brain
44	chr3:271800-277400	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
45	chr3:272000-272800	Weak transcription	iPS-15b Cell Line	embryonic stem cell
46	chr3:272000-274600	Weak transcription	ES-I3 Cell Line	embryonic stem cell
47	chr3:272200-274400	Weak transcription	Cortex derived primary cultured neurospheres	brain
48	chr3:272200-276000	Weak transcription	Brain Hippocampus Middle	brain
49	chr3:272200-276200	Weak transcription	Breast Myoepithelial Primary Cells	Breast
50	chr3:272200-283800	Weak transcription	Fetal Brain Male	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links